Sign in
8-K

Current Report

Oruka Therapeutics, Inc. Filed Acc 0001564590-21-017811

Material agreement · Director nominations

  • Item 1.01 Entry into a material definitive agreement
  • Item 5.08 Shareholder director nominations

From the SEC's structured data for this filing

Loading abio-8k_20210402.htm…